Cargando…

Protective effect of avenanthramides against cisplatin induced nephrotoxicity in rats

OBJECTIVE: The aim of this study is to inspect the ameliorative effect of avenanthramides (AVA) on CP nephrotoxicity in Sprague-Dawley rats. MATERIALS AND METHODS: Blood samples were collected for the determination of hematological parameters. Creatinine, blood urea nitrogen (BUN), and tumor necrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: El Amir, Yasmin O., Omar, Wisam, Khabrani, Amani Y., Jahfali, Amani E., Alhakami, Shahd M., Dobab, Nada M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882723/
https://www.ncbi.nlm.nih.gov/pubmed/31819881
http://dx.doi.org/10.5455/javar.2019.f377
Descripción
Sumario:OBJECTIVE: The aim of this study is to inspect the ameliorative effect of avenanthramides (AVA) on CP nephrotoxicity in Sprague-Dawley rats. MATERIALS AND METHODS: Blood samples were collected for the determination of hematological parameters. Creatinine, blood urea nitrogen (BUN), and tumor necrosis factor-α (TNF-α) were measured in serum. Specimens from both kidneys were taken for histopathological examinations. RESULTS: Administration of AVA resulted in significant decrease in the level of creatinine and TNF-α when compared with CP group. Histopathologically, CP-induced vacuolar degeneration and necrosis of the kidney tubules. Administration of AVA ameliorates the histopathological alterations induced by CP. CONCLUSION: AVA can be considered as a protective agent for kidneys during administration of CP. The protective effect of AVA may be related to the reduction of TNF-α which implicated in the pathogenesis of CP nephrotoxicity.